Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 801 - 825 of 2,711

«
1
…
31
32
33
34
35
…
109
»

2023 Gyn Oncology Updates

2023 Gyn Oncology Updates

By: Don S. Dizon, MD, FACP, FASCO

2023 Gyn Oncology Updates

2023 Gyn Oncology Updates

By: Don S. Dizon, MD, FACP, FASCO

Treating Advanced Or Metastatic Cervical Cancer ADCs, VEGF Inhibitors, And Immunotherapy

Treating Advanced Or Metastatic Cervical Cancer ADCs, VEGF Inhibitors, And Immunotherapy

By: Don S. Dizon, MD, FACP, FASCO

Ovarian Cancer Update: PARP Inhibitors in Ovarian Cancer

Ovarian Cancer Update: PARP Inhibitors in Ovarian Cancer

By: Elizabeth Diver, MD

Role of Immunotherapy in Gynecologic Cancers

Role of Immunotherapy in Gynecologic Cancers

By: Gerado Colon-Otero, MD

Targeted Agents and Chemotherapy in Gynecologic Malignanciess in 2018

Targeted Agents and Chemotherapy in Gynecologic Malignanciess in 2018

By: Gerado Colon-Otero, MD

Advances In The Treatment of Gynecologic Malignancies

Advances In The Treatment of Gynecologic Malignancies

By: Gerardo Colon-Otero, MD

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

By: Gerardo Colon-Otero, MD

Gynecologic Malignancies

Gynecologic Malignancies

By: Gerardo Colon-Otero, MD

What is New On the Treatment of Gynecologic Cancers

What is New On the Treatment of Gynecologic Cancers

By: Gerardo Colon-Otero, MD

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

By: Mark S, Shahin, MD, FACOG, FACS

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

By: Mark S, Shahin, MD, FACOG, FACS

New Directions in the Management of Ovarian Cancer

New Directions in the Management of Ovarian Cancer

By: Mihaela Cristea - MD

State of the Art in Gynecologic Oncology

State of the Art in Gynecologic Oncology

By: Rebecca A. Brooks, MD

State of the Art in Gynecologic Oncology

State of the Art in Gynecologic Oncology

By: Rebecca A. Brooks, MD

Therapeutic Advances in Gynecologic Oncology

Therapeutic Advances in Gynecologic Oncology

By: Rebecca Brooks, MD

Current Status of Cervical Cancer Screening

Current Status of Cervical Cancer Screening

By: Ritu Salani MD, MBA

Current Status of Cervical Cancer Screening

Current Status of Cervical Cancer Screening

By: Ritu Salani MD, MBA

Gynecologic Malignancies: New Targeted Therapy-IO-Chemo Combinations

Gynecologic Malignancies: New Targeted Therapy-IO-Chemo Combinations

By: Ritu Salani, MD, MBA

Gynecologic Malignancies: New Targeted Therapy-IO-Chemo Combinations

Gynecologic Malignancies: New Targeted Therapy-IO-Chemo Combinations

By: Ritu Salani, MD, MBA

Immunotherapy For Uterine Cancer New Standards For Upfront Treatment For Advanced Or Recurrent Disease

Immunotherapy For Uterine Cancer New Standards For Upfront Treatment For Advanced Or Recurrent Disease

By: Ritu Salani, MD, MBA

Gynecologic Cancer Recent Advances in Management

Gynecologic Cancer Recent Advances in Management

By: Tate Thigpen, MD

Gynecologic Cancer

Gynecologic Cancer

By: Tate Thigpen, MD

Immunotherapies in Gynecologic Malignancies

Immunotherapies in Gynecologic Malignancies

By: Thomas Herzog, MD

Targeted Therapies in Ovarian & Other Gynecologic Cancers

Targeted Therapies in Ovarian & Other Gynecologic Cancers

By: Thomas J Herzog, MD

«
1
…
31
32
33
34
35
…
109
»

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok